- Telehealth Visits
- Insurance plan information
Nandita Mandhani, MD
Neonatology- Telehealth Visits
- Insurance plan information
Nandita Mandhani, MD
Neonatology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Nandita Mandhani is a neonatologist, an expert in caring for critically ill newborns. She enjoys managing complex medical and surgical problems, and considers it an honor to walk with families on some of the most challenging journeys of their lives. She has special interests in neonatal neurology, gastrointestinal disorders and extreme prematurity (when a baby is born before 28 weeks of gestation) as well as medical ethics, palliative care and teaching residents.
Mandhani earned her medical degree at the Chhattisgarh Institute of Medical Sciences in India. She completed a residency at Einstein Medical Center Philadelphia and a fellowship at Emory University.
Having resided in three different countries and witnessed the common thread of humanity everywhere, Mandhani is passionate about bridging differences, focusing on common goals and harnessing people's goodness wherever she goes.
Education & training
Board certification
- Neonatal-Perinatal Medicine, American Board of Pediatrics/Neonatal-Perinatal
- Pediatrics, American Board of Pediatrics
Fellowship
- Neonatal-Perinatal Medicine, Emory Univ School of Medicine
Residency
- Pediatrics, Albert Einstein Medical Center GME
Degree
- MD, Chhattisgarh Institute of Med Sciences
My expertise
Specialties
- Neonatology
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223377%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223377%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.